Introduction
Angiotensinogen is the substrate of renin in the renin ± angiotensinogen system (RAS) and is converted into angiotensin I which is the precursor of angiotensin II. Angiotensin II is an important regulator of blood pressure, water and electrolyte homeostasis. 1 Angiotensinogen is primarly synthesized by the liver, 2 although angiotensinogen mRNA is present in several tissues, including adipose tissue. 3 ± 5 The physiological and pathological role of angiotensinogen gene expression in adipose cells is not completely understood. However, it has been suggested that adipose tissue can modulate its own metabolism and hence mass by producing several hormones and proteins that may serve as feedback signals to maintain body fat levels. 6 Adipose angiotensinogen, after conversion to angiotensin II, might be one of these factors. Secretion of angiotensinogen has been shown from rodent adipocytes and in adipocyte cell lines. 5,7 ± 11 Adipose tissue possesses the enzymatic machinery to convert angiotensinogen into angiotensin II. 12 Angiotensin II has been shown to induce differentiation of adipocyte precursors into mature adipocytes by stimulating prostacyclin release 13 and to induce an increase in lipogenesis in 3T3-L1 and human adipocytes. 14 Rats treated with losartan (angiotensin II receptor antagonist) displayed diminished fat mass and fat cell size. 15 Weight loss was reported as a side effect of angiotensin converting enzyme inhibitors. 16, 17 Taken together these data suggest that the angiotensinogen system might be involved in the growth and development of adipose tissue.
The anatomical distribution of adipose tissue appears to play an important role in several disorders associated with atherosclerotic and cardiovascular diseases. Individuals with a predominantly central (`android') distribution of fat experience higher rates of atherosclerotic heart disease, stroke, hypertension, dyslipidaemia and diabetes mellitus than similarly obese individuals whose adipose tissue is distributed in a peripheral pattern (`gynoid'). 18, 19 In particular, accumulation of omental adipose tissue has the strongest association with atherogenic disorders. 20 The metabolic and endocrine activities differ considerably between subcutaneous and omental fat. In addition, omental adipose tissue is drained by the portal vein and has, unlike other fat depots, a direct connection with the liver.
It is not clear how body fat distribution is regulated. However, adipose angiotensinogen might play a role. In male Hutteries, linkage between genetic variation near the angiotensinogen locus on human chromosome 1 and waist-to-hip circumference ratio (WHR), which is an indirect measure of the relative amount of abdominal adipose tissue, was reported, 21 implying that the angiotensinogen gene might be involved in body fat distribution. In this study, we investigated the possible linkage between gene expression of angiotensinogen in adipose tissue and body fat distribution in obese subjects. We studied the relationship between adipose angiotensinogen mRNA expression on the one hand and the WHR on the other. In addition, we tried to establish whether any site-speci®c differences occur in angiotensinogen expression in human adipose tissue, since these might be related to selective expansion of particular adipose depots. In the same obese subjects, we therefore compared angiotensinogen mRNA expression between the abdominal subcutaneous and omental adipose tissue regions.
Methods

Subjects
The study group consisted of 20 obese subjects (12 men, eight women) undergoing weight reduction surgery with adjustable gastric banding. All were otherwise healthy, except three subjects who were treated for mild hypertension with a beta-blocker (two cases) and a loop diuretic (one case). The age of the subjects ranged from 26 to 54 y. WHR and body mass index (BMI) were measured on the day before surgery after an overnight fast. The mean WHR in the whole group was 1.00. For the women 80% of the WHR values were between 0.89 and 1.01, and for the men between 0.98 and 1.09. BMI ranged from 29 to 51 kgam 2 (mean: 41 kgam 2 ). All subjects were Caucasians born in Sweden. The study was approved by the Ethics Committee of the Karolinska Institute (Stockholm, Sweden). All subjects gave informed consent to participate in the study.
Adipose tissue biopsies
The subjects fasted overnight. At 8.00 a.m. they were brought to the operation room. General anaesthesia was given, as previously described. 22 Fat tissue specimens (0.5 ± 1 g) were obtained within 30 min after the incision of the abdominal wall from the subcutaneous and omental fat tissue regions. The tissue pieces were frozen in liquid nitrogen and stored at 770 C for subsequent mRNA analysis. It was possible to obtain omental fat from 18 subjects and subcutaneous fat from 18 subjects. From 16 subjects we obtained tissue from both regions. Before taking the fat biopsies, only saline was administered intravenously.
In addition, adipose tissue from both the subcutaneous and omental fat tissue region from two obese women was obtained and used to isolate fat cells by collagenase treatment. 23 These adipose tissue specimens and adipocytes were only used in methodological experiments.
Construction of the internal standards for the quantitative competitive RT-PCR Angiotensinogen mRNA and 18S ribosomal RNA (18S rRNA) were quanti®ed in the RNA samples from fat tissue and fat cells by quantitative competitive reverse transcriptase-polymerase chain reaction. A heterologous internal standard was constructed that shared primer binding sites with the target RNA and that contained a fucosyltransferase (FUC) internal sequence as well. To construct this internal standard, a PCR was run using a CDM8 plasmid which contained a part of the FUC gene as a template (provided by Jan Holgersson, Clinical Immonology, Huddinge Hospital). The PCR was run with composite primers containing: (1) upstream primer Ð a CGC GGG clamp, a Hind III site, the 5 H speci®c primer sequence for angiotensinogen or 18S and a 5 H FUC primer sequence; and (2) downstream primer Ð a CGC GGG clamp, a Not I site, the 3 H speci®c primer sequence for angiotensinogen or 18S and a 3 H FUC primer sequence. The sequence of these composite primers were as follows (the 5 H or 3 H primer sequences speci®c for angiotensinogen or 18S are underlined):
The PCR product obtained was digested with Hind III and Not I and was ligated into a Hind III and Not I digested CDM8apoly A vector (provided by Jan Holgersson, Clinical Immunology, Huddinge Hospital and Lennart Ra Êhle Ân, Department of Surgery, Huddinge Hospital). Competent bacteria (MC 1061 with P3) were transformed with the ligated vector and spread on LB-agar plates containing ampicillin and tetracycline. Colonies were spread on new plates and grown in LB-medium containing ampicillin and tetracycline. A large-scale DNA preparation was made and an aliquot of this DNA preparation was linearized using Bam HI. The linearized DNA was transcribed Adipose angiotensinogen and upper-body obesity V van Harmelen et al in vitro and the transcription product was DNasetreated using the Riboprobe System-T7 kit (Promega, Stockholm, Sweden). The product (the internal standard) was visualized on a 1% agarose gel containing ethidium bromide, and the concentration was determined spectrophotometrically.
Angiotensinogen mRNA and 18S rRNA analysis
Total RNA was prepared from 300 mg of subcutaneous or omental fat tissue samples, using the RNeasy mini kit (Qiagen, Hilden, Germany). The integrity of the RNA was checked by electrophoresis in a 1% agarose gel containing ethidium bromide. The RNA concentration was measured spectrophotometrically. For competitive RT-PCR, 0.05 mg total RNA was reverse transcribed (RT) and ampli®ed with different amounts of the angiotensinogen internal standard (2.7, 0.9, 0.5, 0.3 and 0.09 pg). Different amounts of the 18S internal standard (11, 3.8, 1.3, 0.4, 0.1 and 0.05 pg) were reverse transcribed with 2 pg total RNA. For the RT-step, total RNA, the internal standard and the speci®c 3 H primer were pre-incubated at 70 C for 10 min. Then the reaction mixture was added and incubated for 5 min at 25 C, 5 min at 37 C and 10 min at 70 C in a PCR apparatus (PTC-200; SDS Co., Falkenberg, Sweden). The ®nal 15 ml reaction mixture in the RT-reaction consisted of 50 mM Tris ± HCl (pH 8. C. The sequences from the speci®c 5 H and 3 H primers are the sequences which are underlined in the composite primers used for the expression cloning (see above). The size of the PCR products were: angiotensinogen and 18S internal standards 250 bp, angiotensinogen sample 199 bp, 18S sample 314 bp. The PCR products were resolved on a 3% agarose gel containing ethidium bromide. A typical example of the gel electrophoresis for angiotensinogen and 18S is depicted in Figure 1 . The gels were scanned using a CCD camera (DIANA 1, Fuji Film AB) and the optical density (OD) of the bands on the gel was determined using TINA 2.09G software. The log (OD internal standardaOD mRNA sample) was plotted as a function of log(internal standard concentration) see Figure 1 ). From this curve the amount of angiotensinogen mRNA or 18S rRNA was calculated in the RNA samples, assuming that the optical densities of the internal standard and the sample are identical when the mRNA concentration of the sample is equal to the internal standard concentration (after correction of size differences of the PCR products of the internal standard and sample). To exclude possible variations in mRNA-yield among samples, the angiotensinogen mRNA was expressed as angiotensinogen mRNA divided per total RNA. The expression of the 18S gene was presumed not to differ between the two fat tissue regions and therefore 18S rRNA was used as a reference RNA. In three cases, there was not enough RNA sample from the subcutaneous adipose specimens to measure both 18S rRNA in addition to angiotensinogen mRNA levels.
Statistical analysis
Results are presented as mean AE s.e.m. All measured parameters were normally distributed. Statistical differences were analysed by Student's paired t-test. The linear regression method (single and multiple) was used to analyse correlations. Analysis of co-variance was used to analyse interactions of a variable with correlations between two other variables. Although 20 subjects were investigated in this study, the number of subjects in the ®gures or tables is not always 20, because of failure to obtain adipose tissue from both regions in some cases or because there was not enough total RNA to measure both 18S rRNA and angiotensinogen mRNA. Figure 1 Quantitative competitive RT-PCR for determination of adipose angiotensinogen mRNA (upper ®gure) and 18S rRNA (lower ®gure) levels. On the left: the RT-PCR products were separated by gel electrophoresis and the optical density (OD) of the bands was determined. M, molecular mass marker. Lanes 1 ± 5: 0.05 mg total RNA was mixed with 2.7, 0.9, 0.5, 0.3 and 0.09 pg angiotensinogen internal standard (IS), respectively. The shorter PCR product represents the adipose RNA sample, the longer PCR product the angiotensinogen IS. Lane 6: H 2 O (negative control). Lanes 7 ± 12: 2 pg total RNA was mixed with 11, 3.8, 1.3, 0.4, 0.1 and 0.05 pg 18S IS, repectively. The shorter PCR product represents the 18S IS, the longer PCR product the adipose RNA sample. On the right: the ratio of log(OD ISaOD mRNA sample) was plotted against log (IS concentration). The dotted line indicates when the concentration of the IS is equal to the concentration of the mRNA, that is when ratio log(OD ISaOD mRNA sample) is equal to zero. For more details see Methods section.
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Results
To study possible regional differences in adipose angiotensinogen mRNA expression, data from 18 subjects were studied. In Figure 2 , it is shown that the steady-state angiotensinogen mRNA level expressed per total RNA was signi®cantly higher in the omental than in the subcutaneous adipose tissue region (paired t-test: P 0.02). The difference in expression was about 33%. The rRNA levels of the reference gene 18S, however, did not differ signi®-cantly between the two adipose tissue regions.
The relationship between WHR and the angiotensinogen mRNA levels in the subcutaneous and omental adipose tissue was determined using linear regression analysis (Figure 3 ). There was a positive and signi®-cant correlation between WHR and angiotensinogen mRNA expression in both the subcutaneous (r 0.49, P 0.04) and the omental adipose tissue (r 0.55, P 0.02). WHR did not correlate signi®cantly with 18S rRNA expression in any of the adipose tissue regions (Figure 4 ). Other regression analyses were also performed. BMI or age did not correlate signi®-cantly with subcutaneous or omental angiotensinogen mRNA expression.
Multiple regression analyses were performed including WHR, age and BMI as the independent parameters and either subcutaneous or omental angiotensinogen mRNA expression as the dependent parameter (Table 1) . After adjusting for BMI and age, WHR was associated with subcutaneous or omental angiotensinogen mRNA expression (r 0.62, P 0.02 (subcutaneous adipose tissue), and r 0.70, P 0.003 (omental adipose tissue)). After adjusting for WHR and age, BMI was signi®cantly associated with omental angiotensinogen mRNA expression (r 0.51, P 0.02), but not with subcutaneous angiotensinogen mRNA expression, although there was a trend (r 0.40, P 0.09).
Both men and women were included and analyzed together in order to obtain a large range in WHR (see Figures 3 and 4 , the open circles are men, the ®lled circles are women). In theory, gender differences in angiotensinogen mRNA expression might exist. The material was too small to allow a thorough investigation of differences related to sex. However, it was investigated whether gender interacted with the cor- Figure 2 Angiotensinogen mRNA (upper) and 18S rRNA (lower) expression in subcutaneous and omental adipose tissue; n 16 for angiotensinogen, n 14 for 18S. Data are means AE s.e.m. Subcutaneous and omental adipose angiotensinogen mRNA levels were compared using a paired t-test. n.s. non-signi®-cant. relations between WHR and subcutaneous or omental angiotensinogen mRNA, using ANCOVA. It was found that gender did not interact signi®cantly with these correlations (F 0.40 for subcutaneous fat, and F 0.02 for omental fat, P n.s.). Three of the subjects were treated for mild hypertension. Also, without these subjects, there were regional differences in adipose angiotensinogen mRNA expression and WHR correlated with adipose angiotensinogen mRNA expression.
Angiotensinogen mRNA was measured in adipose tissue instead of adipocytes. It is possible that the angiotensinogen measured in the samples originates from other cells than adipocytes. In two methodological experiments angiotensinogen mRNA levels in omental and subcutaneous adipose tissue pieces were compared with those in isolated adipocytes from the two adipose tissue regions. Four cell and tissue preparations were investigated. Angiotensinogen mRNA expression was not statistically different between adipose tissue and adipocytes.
Discussion
Angiotensinogen is one of the numerous proteins recently shown to be expressed in adipose tissue. 3 ± 5 Although the function of angiotensinogen in adipose tissue is unknown, several studies indirectly indicate that angiotensinogen, after it has been converted to angiotensin II, might be involved in the control of adipose tissue growth and development. 13 ± 17 In addition, genetic variation near the angiotensinogen locus is associated with WHR in male Hutteries, 21 suggesting that angiotensinogen might regulate body fat distribution as well. The current study implies that angiotensinogen in human adipose tissue is of importance for upper-body fat distribution. The angiotensinogen mRNA levels in both the abdominal subcutaneous and omental adipose tissue correlated positively and signi®cantly with WHR even after adjustment for the possible confounding factors BMI, gender and age. The fact that there was no correlation between adipose 18S rRNA levels and WHR implies that the correlation between adipose angiotensinogen mRNA and WHR is speci®c for angiotensinogen. Men usually tend to gain fat in the abdominal region, whereas women tend to gain fat in the femoral and gluteal regions. To obtain a wide range of WHR in the subject group, both men and women were included. The correlations between angiotensinogen mRNA expression in both adipose tissue regions on the one hand and WHR on the other hand did not differ signi®cantly between men and women. BMI correlated with abdominal adipose angiotensinogen mRNA expression only after adjusting the data for WHR and age. Taken together, the results may indicate that angiotensinogen in adipose tissue is of importance for upper-body fat distribution.
Normal weight subjects were not included, because it was not possible for technical reasons to obtain suf®cient amounts of omental adipose tissue from lean subjects. In severe obesity there tends to be an enlargement of all adipose tissue depots, in both genders. Therefore the range of WHR values in an obese subject group could be narrow, even if one includes both men and women. We compared the WHR values from our subject group with those from a large Swedish population based group studied in the WHO MONICA project. 24 Although the average WHR in our subject group was higher than the average WHR in the population, the range of the WHR values were approximately equally wide (0.76 ± 0.99 (WHO MONICA) vs 0.89 ± 1.09 (current subject group)). This indicates that our obese study group was suitable to study the possible association between adipose angiotensinogen and upper-body fat distribution. However, we cannot exclude angiotensinogen mRNA having a different relationship to body fat distribution in lean subjects. Bearing in mind the probable role of angiotensinogen in the control of adipose tissue growth and development, information on possible site-speci®c differences in adipose angiotensinogen expression could provide insights in the control of body fat distribution. Steady-state angiotensinogen mRNA levels were signi®cantly higher in the omental than in the subcutaneous abdominal adipose tissue. The regional difference was speci®c for angiotensinogen mRNA, as judged by results with 18S rRNA. One can speculate that angiotensinogen in the omental adipose tissue might contribute to the development of abdominal obesity, because abdominal obesity is more associated with omental than subcutaneous abdominal fat. 19 In this respect it is of interest to note that angiotensinogen may regulate adipocyte differentiation in rodent adipose tissue. 25 Because of the limited amount of human adipose tissue that was obtained we could not measure the actual angiotensinogen secretion or angiotensin II production in human adipose tissue. There might be a lack of parallelism between human angiotensinogen mRNA expression and angiotensin II production. Further studies are needed to investigate the possible association between secreted adipose angiotensinogen on the one hand and adipose angiotensin II or abdominal obesity on the other hand.
To summarize, angiotensinogen mRNA in the subcutaneous and omental adipose tissue correlate with WHR and the angiotensinogen mRNA expression is higher in the omental than in the subcutaneous adipose depot. These data suggest that the angiotensinogen might be involved in the development of upper body obesity.
